Ayurveda Panchakarma therapy and Homeopathic medicines for children with Autism

Phase 2

Not yet recruiting

Conditions: Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence. Ayurveda Condition: UNMADAH,

Registration Number: CTRI/2025/06/089282

Lead Sponsor: Parul University

Brief Summary: ASD is Neurobehavior disease affecting the social behaviour and learning skill of child.

Background & Rationale:

Autism Spectrum Disorder (ASD) in children is aneurodevelopmental condition marked by challenges in communication, behavior,and sensory integration. Conventional treatments are often limited tobehavioral therapies and symptomatic pharmacological interventions, withvarying efficacy and potential side effects. Integrative medicalapproaches—particularly Ayurveda and Homeopathy—offer promising adjunctsthrough individualized, holistic care.

Ayurveda Perspective:

Ayurveda conceptualizes ASD in terms of Unmada orVata-predominant neurodevelopmental imbalances, often linked to disturbances inAgni (digestive fire), Ojas (vital essence), and the nervous system (MajjaDhatu). Ayurvedic treatment protocols focus on restoring systemic equilibriumusing medhya rasayana (nootropic herbs), dietary corrections, and Panchakarmaprocedures, thereby aiming to improve cognitive function, social behavior, andphysiological balance in children with ASD.

Homeopathy Perspective:

Homeopathy, based on the principle of individualized remedyselection, has been observed to modulate behavioral and emotional dysregulationin ASD. It addresses the child’s unique symptom profile—emotional, physical,and developmental—to stimulate the body’s innate healing response. This alignswith non-invasive, child-friendly modalities that are crucial in pediatriccare.

Objective:

This trial aims to evaluate the clinical efficacy and safetyof Ayurveda and Homeopathy interventions in the management of pediatric ASDsymptoms. It explores the potential synergistic benefits of integrative,personalized treatments in enhancing quality of life and developmentaloutcomes.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 90

Inclusion Criteria

1 Children with Diagnosed cases of ASD 2 Children with ASD with parents consent to willing to participate in clinical trial 3 Children with score more than 100 on ISAA (Indian Scale for Autism Assessment).

Exclusion Criteria

1 Children age less than 3 years and above 16 years 2 Children with ASD and their parents not willing to participate or giving consent 3 Children with score less than 100 on ISAA (Indian Scale for Autism Assessment) 4 Child with ASD with other neurobehavior diseases, epilepsy and progressive neurological disorders.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1 Improvement in ISAA score	at the time of enrollment \| 30 days \| 60 days \| 90 days \| 120 days
2 Improvement in Cognition and concentration	at the time of enrollment \| 30 days \| 60 days \| 90 days \| 120 days

Secondary Outcome Measures

Name	Time	Method
1 Improvement in social communication	2 Improvement in speech

Trial Locations

Locations (1): Parul Ayurveda Hospital
🇮🇳
Vadodara, GUJARAT, India
Parul Ayurveda Hospital
🇮🇳Vadodara, GUJARAT, India
Dr Swapnil C Raskar
Principal investigator
9726587013
neonatecare2024@gmail.com